Hannah M. Carter

This study shows that kynurenine modulates AHR signaling in specific pulmonary cell types, with pathogenic effects requiring cell-cell interactions, not isolated cell responses.

This paper shows that immunomodulatory nanoparticles reprogram monocytes to resolve pulmonary fibrosis by inducing antifibrotic immune activation and ECM degradation.

This study identifies CD103+ dendritic cell-fibroblast crosstalk via TLR9 and AHR signaling as a driver of lung fibrosis in IPF, showing that inhibiting AHR signaling reduces fibrosis.